1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CDH17 CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA CES2 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA CARMIL2 CTRPv2 pan-cancer AAC -0.15 0.0006
mRNA CTDSP1 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA ECI2 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA PEX3 CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA FGL2 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA STAT5B CTRPv2 pan-cancer AAC -0.14 0.0006
mRNA COL1A2 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA WDR62 CTRPv2 pan-cancer AAC -0.13 0.0006
Download CSV